Brief: Oragenics Extends Collaboration To Develop Vaccines Against Future Variants Of Coronaviruses
06/04/2022 12:35
April 6 (Reuters) - Oragenics Inc OGEN.A :
* ORAGENICS EXTENDS COLLABORATION TO DEVELOP VACCINES
AGAINST
FUTURE VARIANTS OF CORONAVIRUSES
* ORAGENICS INC - EXTENDED A LICENSING AND COLLABORATION
AGREEMENT
WITH NATIONAL RESEARCH COUNCIL OF CANADA
Source text for Eikon: ID:nBw99cryba
Further company coverage: OGEN.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing